Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Miriam E. Tucker

    News

    Bariatric surgery still best option for some with obesity

    Author:
    Miriam E. Tucker
    Publish date: November 28, 2023

    “Sometimes we might need to go straight to surgery instead of going through medications first, because it may be the most effective and evidence-...

    • Read More

    News

    Already-available drug could help treat type 1 diabetes

    Author:
    Miriam E. Tucker
    Publish date: November 21, 2023

    DFMO inhibits the polyamine biosynthesis pathway, which plays a role in the inflammatory responses in autoimmune diseases.

    • Read More

    News

    Salt intake associated with increased type 2 diabetes risk

    Author:
    Miriam E. Tucker
    Publish date: November 13, 2023

    “These findings provide support that reduction of adding salt to foods may act as a potential behavioral intervention approach for preventing T2D...

    • Read More

    News

    FDA approves tirzepatide for treating obesity

    Author:
    Miriam E. Tucker
    Publish date: November 9, 2023

    Zepbound should go to market in the United States by year’s end, with an anticipated monthly list price of $1,060.

    • Read More

    News

    Insulin appears less heat-sensitive than previously thought

    Author:
    Miriam E. Tucker
    Publish date: November 3, 2023

    Although the issue of insulin refrigeration is less urgent in higher-income countries, it does arise when people accidentally leave their unopened...

    • Read More

    News

    Semaglutide prescribing surged in the past year

    Author:
    Miriam E. Tucker
    Publish date: November 1, 2023

    General and family practice providers were the most frequent semaglutide providers (30%), followed by internists (15%).

    • Read More

    News

    More weight loss with time-restricted eating

    Author:
    Miriam E. Tucker
    Publish date: October 30, 2023

    “Our findings ... show that TRE is safe in patients who are using either diet alone or medications to control their [type 2 diabetes].”

    • Read More

    News

    Testosterone replacement benefits men with type 2 diabetes

    Author:
    Miriam E. Tucker
    Publish date: October 18, 2023

    Prior data from Dr. Jones' group showed that about 40% of men with type 2 diabetes have symptomatic testosterone deficiency.

    • Read More

    News

    New ‘twincretin’ pemvidutide: Another option for obesity

    Author:
    Miriam E. Tucker
    Publish date: October 17, 2023

    “We need to look at the person holistically and at other aspects of cardiometabolic health and treat in a personalized way and choose treatments...

    • Read More

    News

    New hyperglycemia emergency guidance updates DKA definition

    Author:
    Miriam E. Tucker
    Publish date: October 11, 2023

    New to the 2023 version will be a strong emphasis on the excess morbidity and mortality risks associated with the increasingly common “hybrid”...

    • Read More

    News

    Precision medicine takes individual approach to diabetes

    Author:
    Miriam E. Tucker
    Publish date: October 6, 2023

    “Because diabetes is an incredibly heterogeneous disease, few people are Mr. or Mrs. ‘average’ and one-size-fits-all approaches fail many people...

    • Read More

    News

    Metformin treatment shows benefit in gestational diabetes

    Author:
    Miriam E. Tucker
    Publish date: October 3, 2023

    “Gestational diabetes is now reaching epidemic proportions. And of course, the vast majority of these women are in low- and middle-income...

    • Read More

    News

    EASD 2023: A deeper dive into type 1 and type 2 diabetes

    Author:
    Miriam E. Tucker
    Publish date: September 26, 2023

    “We always come after [the ADA annual meeting]. That puts us in a position where we can take deeper dives into the data. ... EASD is a calmer...

    • Read More

    News

    Weekly insulin with dosing app beneficial in type 2 diabetes

    Author:
    Miriam E. Tucker
    Publish date: September 26, 2023

    “Once-weekly icodec with a dosing guide app could conceivably address several challenges seen in everyday practice.”

    • Read More

    News

    Are vitamin D levels key to canagliflozin’s fracture risk?

    Author:
    Miriam E. Tucker
    Publish date: September 25, 2023

    “Something as simple as OTC vitamin D might protect against bone fractures caused by chronic multiyear treatment with a drug.”

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery